CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
Tachidinodevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04382482
NCT04382482N/ACompleted

Remotely Controlled Intervention for Developmental Reading and Spelling Disorders

IRCCS Eugenio Medea·observational·Posted May 11, 2020·Updated Mar 22, 2024

In Brief

An observational study evaluating Tachidino for Developmental Dyslexia and Developmental Spelling Disorder. Completed, enrolled 80 participants across 1 site.

Detailed Summary

The study aims to document the effects of the intervention system for specific reading and spelling disorders, currently in use at Scientific Institute (IRCCS) Medea as an innovative intervention model in e-health mode. The model constitutes the application of research data collected in more than fifteen years research on the causes of dyslexia and rehabilitation techniques, combined with the most advanced technologies for remotely-controlled clinical management and therapy monitoring through adaptive, self-updating algorithms. A single group of about 80 children will be observed and their performance on reading, spelling and metaphonological tests at pre-test, post-test and follow-up (after 6 months) will be recorded in order to assess improvement (and, consequently, treatment effectiveness) and its stability. The improvements obtained in four weeks treatment will subsequently be compared with those obtained with outpatient intervention programmes of the same duration and intensity.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 11, 2020
Enrollment StartJan 20, 2018
Primary CompletionDec 1, 2020
Study CompletionJan 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 6.1 years ago

Interventions

Tachidinodevice

Web-platform delivering remote treatment of reading and spelling disorders through the (visual or auditory) presentation of words and sentences to be either decoded or corrected (reordering wrong letter sequences).